CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novozymes A/S - ADR Company Snapshot
Novozymes A/S - ADR operates within the Industrial organic chemicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novozymes A/S - ADR with three other chemical manufacturers in North America: Cabot Corporation (2016 sales of $2.41 billion of which 46% was Reinforcement Materials), HB Fuller Co ($2.09 billion ), and KMG Chemicals, Inc. ($297.98 million of which 88% was Electronic Chemicals).

Sales Analysis. During the year ended December of 2016, sales at Novozymes A/S - ADR were $2.10 billion. This is a very small increase of 1.3% versus 2015, when the company's sales were $2.07 billion. Despite this increase, sales are still below the level achieved in 2014, when Novozymes A/S - ADR reported sales of $2.21 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, Novozymes A/S - ADR had sales of $1.97 billion.
   
   
 
  Stock Performance Chart for Novozymes A/S - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 36.05
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 6.5%  
4 Weeks -15.4%   52 Weeks -16.1%  
 
Novozymes A/S - ADR Key Data:
  Ticker: NVZMY Country: United States
  Exchanges: OTC Major Industry: Materials
    Sub Industry: Chemicals & Allied Products
  2016 Sales 2,097,117,180
(Year Ending Jan 2017).
Employees: 6,485
  Currency: U.S. Dollars Market Cap: 8,791,681,565
  Fiscal Yr Ends: December Shares Outstanding: 243,874,662
  Share Type: Closely Held Shares: 26,071,400
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.